Long-Term Prognosis and Comorbidities Associated with Psoriasis in the Newfoundland and Labrador Founder Population

被引:25
作者
Gulliver, Wayne P. [1 ]
MacDonald, Don
Gladney, Neil
Alaghehbandan, Reza
Rahman, Proton
Baker, K. Adam
机构
[1] Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF A1B 4S8, Canada
关键词
INCREASED RISK; DISEASE; CANCER; MORTALITY; MODERATE; THERAPY; BURDEN; COHORT; COST;
D O I
10.2310/7750.2010.10013
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Psoriasis is a common chronic immune-mediated inflammatory disorder of the skin with several associated comorbidities. Objective: To assess the prevalence of comorbidities in a cohort of psoriasis patients within the Canadian province of Newfoundland and Labrador (NL). Methods: This cross-sectional observational study investigated hospital-coded comorbidities associated with psoriasis in comparison to the general NL hospitalized population. Results: Patients died significantly younger than the general population, with patients having an earlier disease onset (<= 25 years) dying at a younger age than those with a later onset (> 25 years; 59.3 vs 71.2; p = .001). Patients were hospitalized more frequently for several system disorders than the general population, and a potential association was observed between prognostic factors such as age at onset, disease severity, and HLA-Cw6 genotype and certain comorbid conditions. Conclusion: This study supports an association between psoriasis and other conditions, such as circulatory and endocrine diseases.
引用
收藏
页码:37 / 47
页数:11
相关论文
共 32 条
[1]  
[Anonymous], INT CLASS DIS ICD
[2]   Psoriasis and metabolic disease: epidemiology and pathophysiology [J].
Azfar, Rahat S. ;
Gelfand, Joel M. .
CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (04) :416-422
[3]   Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden [J].
Boffetta, P ;
Gridley, G ;
Lindelöf, B .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (06) :1531-1537
[4]   Psoriasis and diabetes: a population-based cross-sectional study [J].
Cohen, A. D. ;
Dreiher, J. ;
Shapiro, Y. ;
Vidavsky, L. ;
Vardy, D. A. ;
Davidovici, B. ;
Meyerovitch, J. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (05) :585-589
[5]   Psoriasis and the metabolic syndrome [J].
Cohen, Amon D. ;
Gilutz, Harel ;
Henkin, Yaakov ;
Zahger, Doron ;
Shapiro, Jonathan ;
Bonneh, Dan Y. ;
Vardy, Daniel A. .
ACTA DERMATO-VENEREOLOGICA, 2007, 87 (06) :506-509
[6]   The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US [J].
Crown, WH ;
Bresnahan, BW ;
Orsini, LS ;
Kennedy, S ;
Leonardi, C .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (12) :1929-1936
[7]  
Fay MP, 1997, STAT MED, V16, P791
[8]   Psychologic factors in psoriasis: Consequences, mechanisms, and interventions [J].
Fortune, DG ;
Richards, HL ;
Griffiths, CEM .
DERMATOLOGIC CLINICS, 2005, 23 (04) :681-+
[9]   The risk of mortality in patients with psoriasis - Results from a population-based study [J].
Gelfand, Joel M. ;
Troxel, Andrea B. ;
Lewis, James D. ;
Kurd, Shanu Kohli ;
Shin, Daniel B. ;
Wang, Xingmei ;
Margolis, David J. ;
Strom, Brian L. .
ARCHIVES OF DERMATOLOGY, 2007, 143 (12) :1493-1499
[10]   Risk of myocardial infarction in patients with psoriasis [J].
Gelfand, Joel M. ;
Neimann, Andrea L. ;
Shin, Daniel B. ;
Wang, Xingmei ;
Margolis, David J. ;
Troxel, Andrea B. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (14) :1735-1741